Bank of New York Mellon Corp Makes New $101.13 Million Investment in DaVita Inc. $DVA

Bank of New York Mellon Corp purchased a new stake in DaVita Inc. (NYSE:DVA - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 454,545 shares of the company's stock, valued at approximately $101,127,000. Bank of New York Mellon Corp owned approximately 0.71% of DaVita at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Invesco Ltd. boosted its holdings in shares of DaVita by 2.0% during the 3rd quarter. Invesco Ltd. now owns 1,679,248 shares of the company's stock valued at $223,122,000 after acquiring an additional 32,358 shares in the last quarter. Morgan Stanley boosted its stake in shares of DaVita by 5.1% during the fourth quarter. Morgan Stanley now owns 1,477,045 shares of the company's stock valued at $167,807,000 after purchasing an additional 71,156 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in shares of DaVita by 114.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,190,000 shares of the company's stock worth $135,196,000 after purchasing an additional 636,191 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of DaVita by 5.2% during the first quarter. Dimensional Fund Advisors LP now owns 1,145,436 shares of the company's stock worth $176,037,000 after purchasing an additional 56,336 shares during the last quarter. Finally, LSV Asset Management increased its stake in shares of DaVita by 1.1% in the fourth quarter. LSV Asset Management now owns 936,768 shares of the company's stock valued at $106,426,000 after buying an additional 9,739 shares during the period. 90.12% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on DVA shares. Barclays lifted their target price on shares of DaVita from $218.00 to $224.00 and gave the stock an "equal weight" rating in a research report on Wednesday, August 5th. Weiss Ratings upgraded shares of DaVita from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, August 5th. Raymond James Financial set a $220.00 price target on shares of DaVita in a research note on Friday, August 7th. TD Cowen upgraded shares of DaVita from a "hold" rating to a "buy" rating and lifted their price target for the stock from $201.00 to $220.00 in a report on Friday, August 7th. Finally, UBS Group boosted their price objective on shares of DaVita from $235.00 to $270.00 and gave the stock a "buy" rating in a research note on Friday, July 10th. Four analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $221.75.

DaVita Price Performance

Shares of DVA stock opened at $176.53 on Tuesday. The stock has a market capitalization of $11.26 billion, a PE ratio of 14.45, a PEG ratio of 0.58 and a beta of 0.88. The business's 50 day simple moving average is $214.30 and its 200 day simple moving average is $182.32. DaVita Inc. has a one year low of $101.00 and a one year high of $247.49.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $4.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.88 by $0.14. DaVita had a net margin of 6.05% and a negative return on equity of 217.63%. The firm had revenue of $3.55 billion during the quarter, compared to analyst estimates of $3.50 billion. During the same quarter last year, the business earned $2.95 EPS. The company's revenue was up 5.2% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, research analysts expect that DaVita Inc. will post 14.57 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Kathleen Alyce Waters sold 15,405 shares of the business's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $208.40, for a total value of $3,210,402.00. Following the transaction, the insider owned 109,194 shares in the company, valued at $22,756,029.60. The trade was a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.90% of the stock is owned by corporate insiders.

About DaVita

DaVita Inc NYSE: DVA is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source